CHRISTINA GILLENWATER: Open Payments
NPI 1811326861 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$938 in 50 payments from 13 companies in 2025. Trend: 2023 $587 · 2024 $984 · 2025 $938
Food & beverage: $938
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $228 |
| Vanda Pharmaceuticals Inc. | 6 | $146 |
| ABBVIE INC. | 9 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $101 |
| Dexcom, Inc. | 5 | $87 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| Lilly USA, LLC | 3 | $52 |
| Boston Scientific Corporation | 1 | $28 |
| PFIZER INC. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
Products named: FANAPT, AIRSUPRA, CAPLYTA, BREZTRI, REXULTI, Dexcom G6 Transmitter, VRAYLAR, MOUNJARO.
Industry payments across AR — which companies pay providers there.
